IRBs speak a variety of languages. For nearly 30 years our IRBs have been fluent in the language of biomedical reviews. We have specialized in all phases of drug and device research and the evaluation of risk that is associated with each. Our IRBs speak more than biomedical, however. Our service languages also include:
- Outcomes Research
- Educational-based Research
- Clinical Effectiveness Research
- Biological Specimens
- Registry Studies
- Grant Reviews
- Focus Groups
- REMS / KABs
Not all research is the same, and neither are the requirements for their review. If your research involves these types of languages we can help you determine when IRB review is required, when voluntary review might be beneficial, and how to decide if your project is exempt or simply not human subjects research. We can help because we speak your language and understand how to administer and review non-invasive research. E&I has learned to apply a “tiered” approach to the studies we review, distinguishing between identifiable-data collections, interaction studies and intervention studies. This method benefits our clients through more appropriate, and often shorter, application forms and review times.
Give us a call to discuss your type of project further…we speak your language.
For more information please contact us.